Investee Company Update: Little Green Pharma Ltd

In brief · summary, not quotable

Portfolio company Little Green Pharma to acquire Health House Australia for AUD $1.25 million cash.

Acquisition price AUD $1.25 million
Health House annual revenue approximately $7.5 million
SEED's stake in LGP ca. 2.4%

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SEED notes

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to note that its portfolio company, Little Green Pharma Ltd ("LGP"), has entered into a binding letter of intent ("LOI") with Health House Australia Pty Ltd ("Health House"), granting LGP exclusive rights to acquire Health House for AUD $1.25 million in cash.

Key Points

Health House operates a nationwide medical cannabis distribution business in Australia1 and has served as a trusted distribution partner of LGP since 2019.
The proposed acquisition aligns with LGP's strategy of capitalising on current market conditions to acquire sustainable medicinal cannabis businesses at attractive valuations.
Health House is cashflow breakeven and generates approximately $7.5 million in annual revenue.
The transaction has the potential to deliver significant operational synergies and strengthen LGP's vertical integration capabilities, while ensuring Health House remains one of LGP's key distribution partners.

LGP's full announcement can be accessed via the following link: https://investlittlegreenpharma.com

1 See https://healthhouse.com.au/

SEED owns 7,324,796 ordinary shares in LGP representing ca. 2.4% of LGP's issued share capital.

Little Green Pharma

Nominated Adviser

About RNS Reach announcements

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.